Michel Orsinger reaffirms commitment to Nobel Biocare but will stand for election as regular Board member only

Köln, (PresseBox) - Michel Orsinger has reaffirmed his commitment to Nobel Biocare through his intention to stand for election to the Board at the company's annual general meeting on 29 March 2012. However, due to other upcoming professional commitments, Michel Orsinger has decided, if he is elected to Nobel Biocare's Board, to focus on various specific areas where he can add value, including leading the company's Innovation and Technology Committee, rather than on heading the Board. Pending a successful re-election to the Board by the shareholders, the Board intends to appoint the current Chairman ad interim, Rolf Watter, as Chairman of the Board of Nobel Biocare.

Nobel Biocare Deutschland GmbH

Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions. As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions from tooth to root, for single tooth to completely edentulous indications. The solutions portfolio covers dental implants (including the key brands NobelActive(TM) , Brånemark System® and NobelReplace®), individualized prosthetics and equipment (NobelProcera(TM) ), guided surgery solutions and biomaterials. Nobel Biocare has over 2'400 employees and recorded revenue of EUR 569.2 million in 2011. The company is headquartered in Zurich, Switzerland. Production takes place at seven sites located in Canada, Israel, Japan, Sweden, and the US. Nobel Biocare has 34 direct sales organizations.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.